BullFrog AI Holdings, Inc., along with its affiliated entities, functions as an advanced digital biopharmaceutical firm. Its core mission involves harnessing artificial intelligence and machine learning (AI/ML) to process and interpret extensive medical and healthcare datasets specifically within the United States. A central offering is bfLEAP, a proprietary AI/ML platform meticulously crafted for the thorough examination of both preclinical and clinical research data. The company has also secured critical intellectual property through licensing agreements. One such accord, with George Washington University, provides rights to utilize siRNA targeting Beta2-spectrin. This technology is being investigated for its therapeutic potential across a spectrum of human conditions, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease (NAFLD), and non-alcoholic steatohepatitis (NASH). Additionally, a partnership with Johns Hopkins University grants access to a distinct Mebendazole formulation, developed for the treatment of various human cancers or neoplastic diseases. Founded in 2017, BullFrog AI Holdings, Inc. operates from its headquarters in Gaithersburg, Maryland.
Subscribe to see Bullfrog AI Holdings, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Bullfrog AI Holdings, Inc. is an ai/ml company headquartered in Gaithersburg, United States. It is publicly listed (BFRG) with a market capitalisation of $12M. Xcout tracks 16 named people at Bullfrog AI Holdings, Inc., including Joshua Blacher (Chief Financial Officer).
10 more named people on record for Bullfrog AI Holdings, Inc., with roles, board committees and tenure — see the full roster →
A few of Bullfrog AI Holdings, Inc.'s closest competitors — see the full list of competitors and alternatives →
Pathos AI, Inc. is an artificial-intelligence-driven biopharmaceutical company that uses multimodal patient and biological data to discover and develop precision medicines. Its work is focused primarily on oncology and serves patients with serious diseases through pharmaceutical and healthcare partnerships.
Sorcero is a certified B Corporation headquartered in Washington, D.C., that provides an artificial intelligence and data intelligence platform for life sciences and medical affairs.
Digital Ether Computing develops adaptive artificial intelligence architectures across two primary divisions focused on life sciences and high-stakes operations. Its Discovery division provides AI-driven platforms for drug discovery, structural biology, and functional genomics, while its Systems division builds deployable, mission-grade intelligence for defense, aerospace, and commercial sectors.
Abzu is an Artificial Intelligence (AI) and Information Technology company headquartered in Copenhagen, Denmark. It serves as a preferred partner for pharma, biotech, and research institutions, focusing on transforming data into insights and accelerating R&D.
Xolani Health System Corp provides artificial intelligence-assisted medical imaging and teleradiology solutions for healthcare providers. Its platform offers tools for collaborative clinical operations and AI diagnostic models to detect conditions such as COVID-19, breast cancer, and malaria from medical scans. The company serves hospitals and healthcare workers by facilitating remote access to radiologists and improving diagnostic speed and accuracy.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.